Paul Carter

Paul Carter currently serves as Non Executive Chairman at Clinigen, Memo Therapeutics AG, and Kyowa Kirin International plc., where Paul also chairs the Audit Committee. Carter holds board positions at OPEN Health, Immatics, and Echosens, including roles as Chair of the Compensation Committee and Member of the Audit Committee at Immatics. As a Senior Advisor at Astorg and Advisor at GLG Institute, Carter brings extensive experience in governance and strategy. Previous board commitments include Awakn Life Sciences and Hutchmed, where Carter was Lead Independent Board Director, engaged in both Audit and Technical Committees and chaired the Remuneration Committee. Educational qualifications include a BA (Hons) in Business Studies from Ealing School of Business and Management and FCMA from The Chartered Institute of Management Accountants.